5-HT2 and 5-HT2B inhibitors mitigate fibrotic phenotype of peritoneal fibroblasts via non-canonical signaling in patients on continuous ambulatory peritoneal dialysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.